Clinical Trials Browser

Phase 1 × Virus Diseases × Lymphoid × Clear all

NCT05387226 2022-05-24

Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma

Phase 1 Unknown

Virus Diseases, Lymphoma, T-Cell